These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4614730)

  • 1. [Blood-brain barrier: I. Kinetics of the distribution of amphetamine H3-in brain structures of the rate after intravenous administration].
    Lindenbaum A; Marcher K; Wepierre J; Cohen Y
    Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):337-47. PubMed ID: 4614730
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneous distribution of dextroamphetamine in rat brain after acute amphetamine administration.
    Valenzuela A; Pla A; Villanueva E
    J Toxicol Clin Exp; 1986; 6(6):369-76. PubMed ID: 3820126
    [No Abstract]   [Full Text] [Related]  

  • 3. Brain to serum distribution of radioactivity of injected ( 3 H)-d-amphetamine in differentially housed mice.
    DeFeudis FV; Marks JH
    Biol Psychiatry; 1973 Feb; 6(1):85-8. PubMed ID: 4710778
    [No Abstract]   [Full Text] [Related]  

  • 4. The regional distribution of amphetamine in rat brain is altered by dosage and by prior exposure to the drug.
    Eison MS; Ellison G; Eison AS
    J Pharmacol Exp Ther; 1981 Jul; 218(1):237-41. PubMed ID: 7241382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood-brain barrier. II. Kinetics of distribution of 3H-parahydroxyamphetamine in brain structures after intravenous administration in the rat].
    Lindenbaum A; Marcher K; Wepierre J; Cohen Y
    Arch Int Pharmacodyn Ther; 1975 May; 215(1):168-76. PubMed ID: 1164084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic studies on the entry of d-amphetamine into the central nervous system: I. Cerebrospinal fluid.
    Simpson LL; Barkai A
    J Pharmacol Exp Ther; 1980 Mar; 212(3):541-5. PubMed ID: 7359354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics and metabolism of amphetamine in the brain of rats of different ages.
    Honecker H; Coper H
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(2):111-21. PubMed ID: 1202363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mobilizable pool of d-amphetamine in adipose after daily administration to rats.
    Sparber SB; Nagasawa S; Burklund KE
    Res Commun Chem Pathol Pharmacol; 1977 Nov; 18(3):423-31. PubMed ID: 928945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of amphetamine levels in rat brain after administration of the choline acetyltransferase inhibitor 4-(1-Naphthylvinyl) pyridine (NVP).
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1975 Jun; 215(2):197-201. PubMed ID: 1164087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute dextro-amphetamine administration does not alter brain myo-inositol levels in humans and animals: MRS investigations at 3 and 18.8 T.
    McGrath BM; McKay R; Dave S; Seres P; Weljie AM; Slupsky CM; Hanstock CC; Greenshaw AJ; Silverstone PH
    Neurosci Res; 2008 Aug; 61(4):351-9. PubMed ID: 18508145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug level of d- and l-amphetamine during intravenous self-administration.
    Yokel RA; Pickens R
    Psychopharmacologia; 1974 Jan; 34(3):255-64. PubMed ID: 4819978
    [No Abstract]   [Full Text] [Related]  

  • 12. Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats.
    Morley KC; Cornish JL; Li KM; McGregor IS
    Pharmacol Biochem Behav; 2004 Oct; 79(2):331-42. PubMed ID: 15501310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue levels of chloroamphetamines in rats and mice.
    Fuller RW; Hines CW
    J Pharm Sci; 1967 Feb; 56(2):302-3. PubMed ID: 6025798
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative effects of acute and chronic administration of amphetamine on local cerebral glucose utilization in the conscious rat.
    Orzi F; Dow-Edwards D; Jehle J; Kennedy C; Sokoloff L
    J Cereb Blood Flow Metab; 1983 Jun; 3(2):154-60. PubMed ID: 6841462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the kinetics of d- and l-amphetamine in the brain of isolated and aggregated rats.
    Lokiec F; Rapin JR; Jacquot C; Cohen Y
    Psychopharmacology (Berl); 1978 Jun; 58(1):73-7. PubMed ID: 97723
    [No Abstract]   [Full Text] [Related]  

  • 16. Tachyphylaxis to d-amphetamine: a reexamination of the phenomenon.
    Simpson LL
    J Pharmacol Exp Ther; 1978 Aug; 206(2):331-8. PubMed ID: 682116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of brain levels of drugs with behavioral effects.
    Maickel RP; Cox RH; Miller FP; Segal DS; Russell RW
    J Pharmacol Exp Ther; 1969 Feb; 165(2):216-24. PubMed ID: 5763057
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors influencing the plasma levels of amphetamine and its metabolites in catheterized rats.
    Pashko S; Vogel WH
    Biochem Pharmacol; 1980 Feb; 29(2):221-5. PubMed ID: 7362635
    [No Abstract]   [Full Text] [Related]  

  • 20. An attempt to correlate the development of tolerance to delta-9-tetrahydrocannabinol and d-amphetamine with their subcellular distribution in rat brain.
    Magour S; Coper H; Fähndrich C
    Pol J Pharmacol Pharm; 1976; 28(6):589-92. PubMed ID: 1012982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.